BLI-489 hydrate

• Catalog No.: PZ0022
• CAS Number: 623564-40-9(anhydrous)
• M. F.: C13H12N3NaO5S
• M. W.: 345.30625
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: sodium (5R)-6-{5H,6H,8H-imidazo[2,1-c][1,4]oxazin-3-ylmethylidene}-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate hydrate
• IUPAC Traditional name: sodium (5R)-6-{5H,6H,8H-imidazo[2,1-c][1,4]oxazin-3-ylmethylidene}-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate hydrate
• Synonyms: WAY-185489; 6-[(5,6-Dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt hydrate

DATABASE IDS

• MDL Number: MFCD22374169
• CAS Number: 623564-40-9(anhydrous)

PROPERTIES

• Empirical Formula (Hill Notation): C13H10N3NaO4S · xH2O
• Purity: ≥98% (HPLC)
• Apperance: powder, yellow
• Solubility: H2O: >20 mg/mL
• Storage Temperature: room temp
• German water hazard class: 3

DETAILS

Description (English)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.

Description (简体中文)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.